Carticept Medical completes $20M Series B financing round Carticept Medical, Inc., a developer of innovative items for the treatment of cartilage osteoarthritis and injuries, today announced that it offers finished a $20 million Series B funding round. New trader SonoSite, Inc vardenafiluk.com . Joined existing investors Domain Associates and New Enterprise Associates. Patrick, President and CEO. ‘For a long period surgeons have been searching for an alternative solution to joint replacement that is more effective than simply cleaning out the joint arthroscopically. In cartilage restoration, we re-grow new use or tissue donated tissue.